Page last updated: 2024-08-23

transferrin and Cancer of the Thyroid

transferrin has been researched along with Cancer of the Thyroid in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.41)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (2.41)	29.6817
2010's	56 (67.47)	24.3611
2020's	23 (27.71)	2.80

Authors

Authors	Studies
Bisceglia, M; Brown, G; Colombatti, A; Ellis, T; Goletz, S; Grasso, S; Magro, G; Müller, EC; Otto, A; Perissinotto, D; Perris, R; Schiappacassi, M	1
Burrow, GN; Eggo, MC; Errick, JE; Ing, KW	1
Barresi, G; Tuccari, G	1
Cheon, GJ; Cho, SW; Choi, H; Chung, JK; Kang, KW; Lee, H; Lee, YA; Paeng, JC; Park, DJ; Park, YJ	1
Kao, YH	1
Guillén-Sacoto, MA; Jankovic Miljus, J; Makiadi-Alvarado, J; Ramirez-Moya, J; Riesco-Eizaguirre, G; Robledo, M; Santisteban, P; Wert-Lamas, L	1
C Ferreira, T; Cavaco, BM; Leite, V; Limbert, E; Simões-Pereira, J	1
Berardinelli, F; Borro, M; Campagna, G; Chianelli, M; Colombini, F; Gentile, G; Giovanetti, A; Lauri, C; Marinaccio, J; Sgura, A; Signore, A; Simmaco, M; Tofani, A; Vitis, M	1
Chan, YC; Chen, WC; Chen, YN; Chi, SY; Chiew, YEW; Chou, CK; Lim, LS; Tsai, JR; Wu, ST; Yang, YT	1
Petti, S; Sunavala-Dossabhoy, G	1
An, YS; Kim, HK; Lee, J; Lee, SJ; Yoon, JK	1
Coerts, HI; de Keizer, B; Marlowe, RJ; Verburg, FA	1
de Luis, D; Díaz-Soto, G; Fernández-Velasco, P; Pérez López, P; Torres Torres, B	1
Al Ghuzlan, A; Anizan, N; Attard, M; Bardet, S; Benisvy, D; Betrian, S; Borget, I; Bournaud, C; Bouvier-Morel, E; Ciappuccini, R; Do Cao, C; Garcia, ME; Godbert, Y; Lacroix, L; Lamartina, L; Leboulleux, S; Lion, G; Sajous, C; Schiazza, A; Schlumberger, M; Taïeb, D; Terroir-Cassou-Mounat, M; Zerdoud, S	1
Fujimoto, Y; Kawaguchi, N; Kido, T; Kouchi, Y; Miyagawa, M; Okada, T; Takata, N; Tsuruoka, S; Uwatsu, K	1
Kitahara, CM; Kwon, TE; Lee, C; Pasqual, E	1
Hong, KH; Hong, YT; Lim, ST	1
Abe, K; Horiuchi, K; Ishizaki, U; Kanaya, K; Okamoto, T; Ono, T; Sakai, S	1
Hehenwarter, L; Pirich, C; Rendl, G; Rettenbacher, L; Schweighofer-Zwink, G	1
Loke, KSH; Loo, TP; Ming, WY; Peiling, Y; Sarah, TB; Soon, TY; Yien, LS	1
Iizuka, Y; Inoue, M; Katagiri, T; Mizowaki, T; Nakamura, K; Ogura, K	1
Alibrandi, A; Baldari, S; Campennì, A; Capoccetti, F; Comis, AD; Giovanella, L; Lanzafame, H; Romano, D; Ruggeri, RM; Siracusa, M; Vento, A	1
Chiu, HK; Kim, J; Leung, AM; Pyo, HQ; Schumm, MA; Tseng, CH; Yeh, MW	1
Akkielah, LA; Alguwaihes, A; Alhaddad, MA; Alhaddad, S; Alharbi, M; Alzahrani, S; Jammah, AA; Masood, A	1
Fujimoto, K; Hataya, Y; Matsuoka, N; Okubo, M	1
Kanamori, R; Seto, T; Yamane, S	1
Ahn, BC; Hong, CM; Jeong, JH; Jeong, SY; Jung, JH; Kim, CY; Lee, CH; Lee, J; Lee, SW; Son, SH	1
Baxi, SS; Boucai, L; Dunn, LA; Fagin, JA; Fish, S; Ghossein, RA; Grewal, RK; Haque, S; Ho, AL; Knauf, JA; Larson, SM; Li, D; Ni, A; Pentlow, KS; Pfister, DG; Sabra, MM; Seshan, VE; Sherman, EJ; Tchekmedyian, V; Tuttle, RM; Walters, J	1
Dehbi, HM; Hackshaw, A; Harmer, C; Mallick, U; Newbold, K; Wadsley, J	1
Campos, D; González, P; Paillahueque, G; Spuler, J	1
Duntas, LH; Giovanella, L	1
Deandreis, D; Domínguez, JM; Fagin, JA; Gavane, S; Ghossein, RA; Grewal, RK; Haque, S; Ho, AL; Larson, SM; Leboeuf, R; Pentlow, KS; Pfister, DG; Ricarte-Filho, JC; Shen, R; Sherman, EJ; Tuttle, RM; Zanzonico, PB	1
Hackshaw, A; Kadalayil, L; Mallick, U	1
Macková, M; Vlček, P	1
Schlechte, JA	1
Jiskra, J	1
Bongaerts, AH; Coppes, MH; Glaudemans, AW; Links, TP; Wolffenbuttel, BH	1
Carrilho, F; Carvalheiro, M; Costa, G; da Rocha, AG; Martins, MJ; Melo, M; Ribeiro, C; Soares, P; Sobrinho-Simões, M	1
Balaguer, MG; Bartenstein, P; Basso, M; Calabuig, EC; Haug, A; Magner, J; Maini, CL; Mazzarotto, R; Monari, F; Muros de Fuentes, MA; Petrich, T; Rodrigues, FJ; Sciuto, R; Vallejo Casas, JA; Vaňó, RS; Vianello, F	1
Abujrad, H; Gagnon, A; Irobi, C; Lochnan, HA; Sorisky, A	1
Campbell, J; Fink-Bennett, D; Wu, D	1
Huo, Z; Li, X; Lin, Y; Tu, J; Wang, S	1
Cohen, O; Mylonas, C; Omry, G; Rotenberg, G; Zwas, ST	1
Abhyankar, A; Awasare, S; Basu, S; Kaisar, S; Rani, D	1
Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D	1
Calsolari, MR; Rosario, PW; Siman, TL	1
Magner, J; Weiss, R	1
Gonzalez, ME; Muttikkal, TJ; Rehm, PK	1
Dotan, I; Mitmaker, EJ; Paliouras, M; Roche, PJ; Trifiro, MA	1
Mourão, GF; Rosario, PW	1
Bartolini, P; Buchpiguel, CA; da Silva, MA; Gonzalez, JA; Guimarães, MI; Okazaki, K; Ribela, MT; Valgôde, FG; Yoriyaz, H	1
Abelleira, E; Cross, G; Pitoia, F	1
Chen, MK; Cheng, DW; Doddamane, I	1
Dietlein, M; Dueren, C; Eichhorn, W; Grimm, J; Groth, P; Luster, M; Plenzig, F; Reiners, C; Steinke, R	1
Roberts, V; Vethakkan, SR; Ward, GM	1
Busemeyer, S; Dietlein, M; Kobe, C; Schicha, H; Schmidt, M; Theissen, P	1
Rosario, PW; Xavier, AC	1
Endo, K; Higashi, T; Ikekubo, K; Ishikawa, N; Kanbe, M; Konishi, J; Kubo, A; Kusakabe, K; Maki, M; Nakada, K; Tamaki, N; Yokoyama, K	1
Balzan, S; Bottoni, A; Carpi, A; Evangelista, M; Iervasi, G; Nicolini, G; Pollastri, A	1
Borić, M; Jukić, T; Kusić, Z; Murgić, J; Prpić, M; Stanicić, J	1
Bailey, M; Cherk, MH; Francis, P; Kalff, V; Topliss, DJ	1
Agabiti Rosei, E; Agosti, B; Cappelli, C; Castellano, M; Chiovato, L; De Martino, E; Gandossi, E; Pirola, I; Rotondi, M	1
Calsolari, MR; Lacerda, RX; Mineiro Filho, AF; Rosario, PW	1
Burman, KD; Jonklaas, J; Klubo-Gwiezdzinska, J; Mete, M; Van Nostrand, D; Wartofsky, L	1
Dietlein, M; Eschner, W; Kahraman, D; Kobe, C; Schmidt, M; Schneider, C	1
Bockisch, A; Görges, R; Lodemann, E	1
Amdur, RJ; Dan, T; Mazzaferri, E	1
Abdel-Hamid, A; Alvarez, P; Beare, S; Clark, PM; Clarke, S; Farnell, K; Forsyth, S; Franklyn, JA; Gerrard, G; Hackshaw, A; Hardman, J; Harmer, C; John, R; Kadalayil, L; Lemon, C; Macias, E; Mallick, U; McCready, R; Moss, L; Newbold, K; Nicol, A; Nutting, CM; Roques, T; Smellie, J; Vijayan, R; Wadsley, J; Whitaker, S; Yap, B	1
Alexander, EK; Larsen, PR	1
Chindris, AM; Crook, JE; Diehl, NN; Fatourechi, V; Smallridge, RC	1
Bagnasco, M; Banti, E; Bombardieri, E; Dottorini, ME; Fugazzola, L; Maffioli, L; Perotti, G; Rubello, D; Seregni, E; Testori, O	1
Takano, T	1
Links, TP; van der Horst-Schrivers, AN	1
Kuang, A; Liu, B	1
Freeman, JL; Orlov, S; Walfish, PG	1
Loo, SW	1
Gerard, SK; Park, HM	1
Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S	1
Molinaro, E; Pieruzzi, L; Viola, D	1
Freudenberg, LS; Hänscheid, H; Luster, M; Verburg, FA	1
Lassmann, M; Luster, M; Reiners, C	1
Calsolari, MR; Furtado, Mde S; Lacerda, RX; Mineiro Filho, AF; Rosario, PW	1
Cavallo, A; Pitoia, F	1

Reviews

13 review(s) available for transferrin and Cancer of the Thyroid

Article	Year
Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review. Oral oncology, 2023, Volume: 136 Topics: Humans; Iodine Radioisotopes; Retrospective Studies; Salivary Glands; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyrotropin Alfa	2023
Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies. European journal of endocrinology, 2023, Feb-14, Volume: 188, Issue:2 Topics: Humans; Hypothyroidism; Iodine Radioisotopes; Prospective Studies; Recombinant Proteins; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Treatment Outcome	2023
MANAGEMENT OF ENDOCRINE DISEASE: The role of rhTSH in the management of differentiated thyroid cancer: pros and cons. European journal of endocrinology, 2019, Volume: 181, Issue:4 Topics: Disease Management; Humans; Injections, Intramuscular; Thyroid Neoplasms; Thyrotropin Alfa	2019
[Current trends in treatment and follow-up of patients with differentiated thyroid carcinoma - experience with the use of recombinant human thyrotropin]. Vnitrni lekarstvi, 2013, Volume: 59, Issue:2 Topics: Carcinoma; Humans; Iodine Radioisotopes; Thyroid Neoplasms; Thyrotropin Alfa	2013
Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: a meta-analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 110, Issue:1 Topics: Humans; Iodine Radioisotopes; Quality of Life; Randomized Controlled Trials as Topic; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa	2014
Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management. Current opinion in oncology, 2010, Volume: 22, Issue:1 Topics: Humans; Iodine Radioisotopes; Thyroid Neoplasms; Thyrotropin Alfa	2010
Postoperative use of radioiodine (131-I): review of recommendations and guidelines. Collegium antropologicum, 2011, Volume: 35, Issue:2 Topics: Humans; Iodine Radioisotopes; Practice Guidelines as Topic; Thyroid Neoplasms; Thyrotropin Alfa	2011
[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH]. Minerva medica, 2012, Volume: 103, Issue:3 Topics: Carcinoma; Clinical Trials, Phase II as Topic; Humans; Iodine Radioisotopes; Italy; Neoplasm Recurrence, Local; Neoplasm, Residual; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2012
[Clinical application of recombinant human thyroid-stimulating hormone in management of differentiated thyroid carcinoma]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2012, Volume: 29, Issue:3 Topics: Humans; Iodine Radioisotopes; Thyroglobulin; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa	2012
Radioiodine post-surgical remnant ablation in patients with differentiated thyroid cancer: news from the last 10 years. Journal of endocrinological investigation, 2012, Volume: 35, Issue:6 Suppl Topics: Carcinoma, Papillary, Follicular; Catheter Ablation; Cell Differentiation; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neoplasm, Residual; Thyroid Neoplasms; Thyrotropin Alfa; Time Factors	2012
Radioiodine therapy of metastatic lesions of differentiated thyroid cancer. Journal of endocrinological investigation, 2012, Volume: 35, Issue:6 Suppl Topics: Carcinoma, Papillary, Follicular; Cell Differentiation; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyrotropin Alfa	2012
Recombinant human thyrotropin: safety and quality of life evaluation. Journal of endocrinological investigation, 2012, Volume: 35, Issue:6 Suppl Topics: Cell Differentiation; Evaluation Studies as Topic; Humans; Quality of Life; Thyroid Neoplasms; Thyrotropin Alfa	2012
[Thyroid cancer. In search of individualized treatment]. Medicina, 2012, Volume: 72, Issue:6 Topics: Ablation Techniques; Humans; Incidence; Neck Dissection; Precision Medicine; Prevalence; Risk Factors; Thyroid Gland; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome	2012

Trials

7 trial(s) available for transferrin and Cancer of the Thyroid

Article	Year
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2023, 07-05, Volume: 29, Issue:13 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Iodine Radioisotopes; Mutation; Oximes; Prospective Studies; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Thyroid Neoplasms; Thyrotropin Alfa	2023
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. The lancet. Diabetes & endocrinology, 2019, Volume: 7, Issue:1 Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; United Kingdom; Young Adult	2019
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. The New England journal of medicine, 2013, Feb-14, Volume: 368, Issue:7 Topics: Adult; Aged; Benzimidazoles; Female; Humans; Iodine Radioisotopes; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Middle Aged; Mitogen-Activated Protein Kinases; Multimodal Imaging; Mutation; Neoplasm Metastasis; Positron-Emission Tomography; Radiometry; Symporters; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed	2013
Serum fetuin-A levels following recombinant human thyroid-stimulating hormone stimulation. Clinical and investigative medicine. Medecine clinique et experimentale, 2013, Oct-01, Volume: 36, Issue:5 Topics: Adult; alpha-2-HS-Glycoprotein; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine	2013
[Assessment of the efficacy, safety and pharmacokinetics of SKG-02 (recombinant human TSH) in postoperative diagnosis of well-differentiated thyroid cancer--a Japanese prospective, controlled, multicenter open-label study]. Kaku igaku. The Japanese journal of nuclear medicine, 2010, Volume: 47, Issue:4 Topics: Aged; Asian People; Carcinoma; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Postoperative Period; Prospective Studies; Radionuclide Imaging; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Whole Body Imaging	2010
Acute effect of TSH on oxygenation state and volume of erythrocytes from subjects thyroidectomized for differentiated thyroid carcinoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2011, Volume: 65, Issue:5 Topics: Carbon Dioxide; Cell Size; Erythrocytes; Female; Humans; Hydrogen-Ion Concentration; Iodine Radioisotopes; Male; Middle Aged; Oxygen; Partial Pressure; Receptors, Thyrotropin; Recombinant Proteins; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine	2011
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. The New England journal of medicine, 2012, May-03, Volume: 366, Issue:18 Topics: Ablation Techniques; Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Length of Stay; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome; Young Adult	2012

Other Studies

63 other study(ies) available for transferrin and Cancer of the Thyroid

Article	Year
Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas. The American journal of pathology, 2003, Volume: 163, Issue:1 Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Carcinoma, Papillary; Epitopes; Female; Humans; Keratan Sulfate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Protein Isoforms; Proteome; Spectrometry, Mass, Electrospray Ionization; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Transferrin	2003
Growth and differentiation in cultured human thyroid cells: effects of epidermal growth factor and thyrotropin. In vitro cellular & developmental biology : journal of the Tissue Culture Association, 1986, Volume: 22, Issue:1 Topics: Cell Differentiation; Cells, Cultured; Culture Media; DNA Replication; Epidermal Growth Factor; Epithelium; Fluorescent Antibody Technique; Hormones; Humans; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Thyrotropin; Transferrin	1986
Iron-binding proteins in thyroid tumours. An immunocytochemical study. Pathology, research and practice, 1987, Volume: 182, Issue:3 Topics: Carrier Proteins; Ferritins; Histocytochemistry; Humans; Immunochemistry; Iron-Binding Proteins; Lactoferrin; Thyroid Neoplasms; Transferrin; Transferrin-Binding Proteins	1987
Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration. PloS one, 2021, Volume: 16, Issue:9 Topics: Adult; Aged; Diet; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Retrospective Studies; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Urine	2021
Thyroid : official journal of the American Thyroid Association, 2022, Volume: 32, Issue:3 Topics: Humans; Iodine Radioisotopes; Radiobiology; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine	2022
Circulating MicroRNA Profiles as Potential Biomarkers for Differentiated Thyroid Cancer Recurrence. The Journal of clinical endocrinology and metabolism, 2022, 04-19, Volume: 107, Issue:5 Topics: Adenocarcinoma; Biomarkers; Circulating MicroRNA; Humans; Longitudinal Studies; MicroRNAs; Recombinant Proteins; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2022
Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao. Thyroid : official journal of the American Thyroid Association, 2022, Volume: 32, Issue:3 Topics: Humans; Iodine Radioisotopes; Radiobiology; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine	2022
Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:10 Topics: Adenocarcinoma; Chromosome Aberrations; DNA Damage; Humans; Hypothyroidism; In Situ Hybridization, Fluorescence; Iodine Radioisotopes; Reactive Oxygen Species; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2022
Recombinant human thyrotropin versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer: Experience in a South Taiwanese medical center. The Kaohsiung journal of medical sciences, 2023, Volume: 39, Issue:2 Topics: Adenocarcinoma; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Recombinant Proteins; Retrospective Studies; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Treatment Outcome; Withholding Treatment	2023
Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients. Scientific reports, 2023, 01-05, Volume: 13, Issue:1 Topics: Humans; Kidney; Recombinant Proteins; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2023
Predictive value and dynamic risk stratification of high sensitive basal or stimulated thyroglobulin assay in a long-term thyroid carcinoma cohort. Endocrine, 2023, Volume: 81, Issue:1 Topics: Adult; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Prospective Studies; Risk Assessment; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyrotropin Alfa	2023
Effect of preparation method for radioactive iodine therapy on serum electrolytes. Japanese journal of radiology, 2023, Volume: 41, Issue:11 Topics: Electrolytes; Humans; Hyperkalemia; Hyponatremia; Iodine Radioisotopes; Potassium; Retrospective Studies; Sodium; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2023
Absorbed dose coefficients for adult thyroid cancer patients undergoing radioiodine therapy. Journal of radiological protection : official journal of the Society for Radiological Protection, 2023, 05-25, Volume: 43, Issue:2 Topics: Adult; Humans; Iodine; Iodine Radioisotopes; Retrospective Studies; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2023
Voice Outcome of Total Thyroidectomy in Comparison With Administration of Recombinant Human TSH. Journal of voice : official journal of the Voice Foundation, 2021, Volume: 35, Issue:2 Topics: Humans; Iodine Radioisotopes; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Voice	2021
Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer. Annals of nuclear medicine, 2020, Volume: 34, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Japan; Male; Middle Aged; Retrospective Studies; Risk Assessment; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Time Factors; Treatment Outcome; Whole Body Imaging	2020
Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2020, Volume: 52, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Whole Body Imaging	2020
Radiation exposure to allied health personnel handling blood specimens from patients receiving radioactive iodine-131 and recombinant human TSH (thyrogen®) stimulation. Journal of radiological protection : official journal of the Society for Radiological Protection, 2021, Nov-09, Volume: 41, Issue:4 Topics: Allied Health Personnel; Humans; Iodine Radioisotopes; Radiation Exposure; Recombinant Proteins; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2021
Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer. Annals of nuclear medicine, 2020, Volume: 34, Issue:10 Topics: Adult; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk; Thyroglobulin; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa	2020
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:8 Topics: Humans; Iodine Radioisotopes; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyrotropin Alfa	2021
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults. Clinical endocrinology, 2021, Volume: 95, Issue:2 Topics: Adolescent; Child; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Recombinant Proteins; Retrospective Studies; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyrotropin Alfa; Young Adult	2021
Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial. Frontiers in endocrinology, 2020, Volume: 11 Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Biomarkers, Tumor; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Young Adult	2020
Influence of Levothyroxine With Recombinant Human Thyroid-Stimulating Hormone on Urinary Iodine Excretion Before Radioactive Iodine Administration. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2021, Volume: 27, Issue:10 Topics: Humans; Iodine; Iodine Radioisotopes; Recombinant Proteins; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Thyroxine	2021
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study. Advances in therapy, 2021, Volume: 38, Issue:9 Topics: Humans; Iodine Radioisotopes; Japan; Product Surveillance, Postmarketing; Recombinant Proteins; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2021
I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer: comparison between recombinant human TSH administration and thyroid hormone withdrawal. Annals of nuclear medicine, 2017, Volume: 31, Issue:8 Topics: Chemoradiotherapy; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome; Whole Body Imaging	2017
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers. The Journal of clinical endocrinology and metabolism, 2019, 05-01, Volume: 104, Issue:5 Topics: Adult; Aged; Cell Dedifferentiation; Cell Differentiation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiation Tolerance; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Vemurafenib	2019
[Intravenous radioiodine and recombinant human TSH in a patient with extensive thyroid cáncer. Report of one case]. Revista medica de Chile, 2018, Volume: 146, Issue:10 Topics: Administration, Intravenous; Aged; Antineoplastic Agents; Gastrostomy; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine; Tracheostomy; Treatment Outcome	2018
Well-being after radiation therapy in thyroid cancer. The New England journal of medicine, 2013, Feb-14, Volume: 368, Issue:7 Topics: Female; Humans; Iodine Radioisotopes; Male; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2013
Update in endocrinology: evidence published in 2012. Annals of internal medicine, 2013, Jun-04, Volume: 158, Issue:11 Topics: Biliopancreatic Diversion; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diphosphonates; Fatty Acids, Omega-3; Female; Fractures, Bone; Gastrectomy; Gastric Bypass; Gene Expression; Gene Expression Profiling; Glucose Intolerance; Hip Fractures; Humans; Hypoglycemic Agents; Imidazoles; Insulin, Long-Acting; Iodine Radioisotopes; Male; Metformin; Obesity; Obesity, Morbid; Osteoporosis; Spinal Fractures; Thiazolidinediones; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Thyrotropin Alfa; Vitamin D	2013
[Current trends in treatment and follow-up of patients with differentiated thyroid carcinoma--experience with the use of recombinant human thyrotropin]. Vnitrni lekarstvi, 2013, Volume: 59, Issue:2 Topics: Carcinoma; Humans; Thyroid Neoplasms; Thyrotropin Alfa	2013
Unexpected symptoms after rhTSH administration due to occult thyroid carcinoma metastasis. The Netherlands journal of medicine, 2013, Volume: 71, Issue:5 Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyrotropin Alfa	2013
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:11 Topics: Adult; Cell Differentiation; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa	2013
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal. Thyroid : official journal of the American Thyroid Association, 2014, Volume: 24, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm, Residual; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome; Young Adult	2014
Thyroid remnant ablation following administration of a diagnostic dose of iodine-131 under thyrogen stimulation. Thyroid : official journal of the American Thyroid Association, 2014, Volume: 24, Issue:5 Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Postoperative Complications; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome	2014
Recombinant human thyroid-stimulating hormone in radioiodine thyroid remnant ablation. The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:2 Topics: Ablation Techniques; Adult; Aged; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Israel; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Grading; Neoplasm Staging; Outcome Assessment, Health Care; Postoperative Complications; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome; Ultrasonography	2014
Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:9 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa; Young Adult	2014
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. European journal of endocrinology, 2014, Volume: 171, Issue:2 Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Substance Withdrawal Syndrome; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Thyroxine; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Triiodothyronine; Tumor Burden	2014
Day 3 thyroglobulin ≤ 1 ng/ml after recombinant human TSH just prior to radioactive iodine is predictive of low risk for persistent/recurrent disease in patients with papillary thyroid carcinoma. Endocrine, 2015, Volume: 49, Issue:1 Topics: Ablation Techniques; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Child; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiography; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Ultrasonography; Whole Body Imaging; Young Adult	2015
Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation. Thyroid : official journal of the American Thyroid Association, 2015, Volume: 25, Issue:6 Topics: Biomarkers, Tumor; Humans; Radioimmunoassay; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa	2015
Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa). Journal of radiology case reports, 2015, Volume: 9, Issue:6 Topics: Aged; Carcinoma, Papillary; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Radiation Dosage; Radionuclide Imaging; Sialadenitis; Thyroid Gland; Thyroid Neoplasms; Thyrotropin Alfa	2015
Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PloS one, 2016, Volume: 11, Issue:2 Topics: Animals; Antibodies, Neoplasm; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Drug Delivery Systems; Humans; Low-Level Light Therapy; Nanotubes, Carbon; Neoplasm Proteins; Receptors, Thyrotropin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa	2016
Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy? Archives of endocrinology and metabolism, 2016, Volume: 60, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Young Adult	2016
Cytogenetic and dosimetric effects of (131)I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments. Radiation and environmental biophysics, 2016, Volume: 55, Issue:3 Topics: Adult; Chromosome Aberrations; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Lymphocytes; Middle Aged; Radiation Dosage; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine	2016
Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH. Endocrine, 2017, Volume: 55, Issue:1 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome; Young Adult	2017
The use of thyrogen in the treatment of differentiated thyroid carcinoma: an intraindividual comparison of clinical effects and implications of daily life. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010, Volume: 118, Issue:8 Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Quality of Life; Thyroglobulin; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome	2010
Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases. Internal medicine journal, 2009, Volume: 39, Issue:12 Topics: Carcinoma, Papillary; Female; Hemoptysis; Humans; Hypoxia; Lung Neoplasms; Middle Aged; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Treatment Outcome	2009
Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma. Nuklearmedizin. Nuclear medicine, 2010, Volume: 49, Issue:6 Topics: Carcinoma; Carcinoma, Papillary; Fatigue; Female; Hospitalization; Humans; Hypothyroidism; Male; Recombinant Proteins; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2010
Recombinant human thyroid stimulating hormone in thyroid remnant ablation with 1.1 GBq 131iodine in low-risk patients. American journal of clinical oncology, 2012, Volume: 35, Issue:2 Topics: Adult; Aged; Autoantibodies; Biopsy, Fine-Needle; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine; Time Factors; Treatment Outcome; Ultrasonography	2012
Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal. Clinical endocrinology, 2012, Volume: 76, Issue:5 Topics: Autoantibodies; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Neoplasm, Residual; Outcome Assessment, Health Care; Retrospective Studies; Risk Assessment; Risk Factors; Thyroglobulin; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa	2012
Usefulness of repeated recombinant human thyrotropin-stimulated thyroglobulin test in the post-surgical follow-up of very low-risk patients with differentiated thyroid carcinoma. Journal of endocrinological investigation, 2012, Volume: 35, Issue:5 Topics: Adenocarcinoma, Papillary; Biological Assay; Cell Differentiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Risk Factors; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2012
Long-term follow-up of at least five years after recombinant human thyrotropin compared to levothyroxine withdrawal for thyroid remnant ablation with radioactive iodine. Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:3 Topics: Adult; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine	2012
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:3 Topics: Adult; Aged; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa	2012
Recombinant human TSH increases uptake and effective half-life of radioiodine in thyroid hormone secreting metastases of follicular thyroid cancer. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012, Volume: 120, Issue:3 Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Female; Half-Life; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Metastasis; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome; Up-Regulation	2012
Short-term hypothyroidism in thyroid cancer patients and cognitive-motor performance relevant for driving. Psychoneuroendocrinology, 2012, Volume: 37, Issue:10 Topics: Adult; Automobile Driving; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Psychomotor Performance; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine	2012
Absence of bone marrow toxicity in elderly patients treated with recombinant human thyroid-stimulating hormone and empirically dosed radioiodine for thyroid cancer. American journal of clinical oncology, 2013, Volume: 36, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Bone Marrow; Cohort Studies; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Geriatric Assessment; Humans; Iodine Radioisotopes; Male; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Survival Rate; Thyroid Neoplasms; Thyrotropin Alfa; Time Factors; Treatment Outcome	2013
Radioiodine for thyroid cancer--is less more? The New England journal of medicine, 2012, May-03, Volume: 366, Issue:18 Topics: Female; Humans; Iodine Radioisotopes; Male; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2012
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:8 Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Radiography, Thoracic; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Ultrasonography	2012
[Endocrine disease: progress in diagnosis and treatment. Topics: I. Progress in diagnosis; 2. thyroid disease, 1) pitfalls in diagnosing thyroid carcinoma and the use of recombinant TSH in iodide scintigraphy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Apr-10, Volume: 101, Issue:4 Topics: Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Humans; Radionuclide Imaging; Thyroid Neoplasms; Thyrotropin Alfa	2012
Thyroid cancer: successful remnant ablation-what is success? Nature reviews. Endocrinology, 2012, Volume: 8, Issue:9 Topics: Female; Humans; Iodine Radioisotopes; Male; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2012
Radioiodine ablation in low-risk thyroid cancer. The New England journal of medicine, 2012, 08-16, Volume: 367, Issue:7 Topics: Female; Humans; Iodine Radioisotopes; Male; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa	2012
Radioiodine ablation in low-risk thyroid cancer. The New England journal of medicine, 2012, 08-16, Volume: 367, Issue:7 Topics: Female; Humans; Iodine Radioisotopes; Male; Thyroid Neoplasms; Thyrotropin Alfa	2012
Radioiodine ablation in low-risk thyroid cancer. The New England journal of medicine, 2012, 08-16, Volume: 367, Issue:7 Topics: Female; Humans; Iodine Radioisotopes; Male; Thyroid Neoplasms; Thyrotropin Alfa	2012
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma. The British journal of radiology, 2012, Volume: 85, Issue:1018 Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult	2012
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence. Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Thyroxine; Tomography, X-Ray Computed; Whole Body Imaging	2012